
David A. Saunders
Examiner (ID: 251)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644, 1621, 1802, 1816, 1801, 1208, 2899, 1633 |
| Total Applications | 1367 |
| Issued Applications | 898 |
| Pending Applications | 119 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 800399
[patent_doc_number] => 07425543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-16
[patent_title] => 'Microencapsulated materials and method of making same'
[patent_app_type] => utility
[patent_app_number] => 10/231791
[patent_app_country] => US
[patent_app_date] => 2002-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 26
[patent_no_of_words] => 12131
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/425/07425543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231791
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231791 | Microencapsulated materials and method of making same | Aug 28, 2002 | Issued |
Array
(
[id] => 7429774
[patent_doc_number] => 20040001848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Method of producing disease-specific antigens'
[patent_app_type] => new
[patent_app_number] => 10/231213
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26966
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001848.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231213 | Method of producing disease-specific antigens | Aug 27, 2002 | Abandoned |
Array
(
[id] => 359559
[patent_doc_number] => 07485438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-03
[patent_title] => 'Method of producing polyvalent antigens'
[patent_app_type] => utility
[patent_app_number] => 10/231114
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26788
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/485/07485438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231114 | Method of producing polyvalent antigens | Aug 27, 2002 | Issued |
Array
(
[id] => 6696349
[patent_doc_number] => 20030108543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Photophoretic auto immune stimulation'
[patent_app_type] => new
[patent_app_number] => 10/229708
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5016
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10229708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/229708 | Photophoretic auto immune stimulation | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6701596
[patent_doc_number] => 20030224476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Method of producing transglutaminase reactive compound'
[patent_app_type] => new
[patent_app_number] => 10/231063
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26907
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231063
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231063 | Method of producing transglutaminase reactive compound | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6821692
[patent_doc_number] => 20030219853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Method of cross-linking a compound'
[patent_app_type] => new
[patent_app_number] => 10/231298
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26869
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231298 | Method of cross-linking a compound | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6861072
[patent_doc_number] => 20030092080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens'
[patent_app_type] => new
[patent_app_number] => 10/229567
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19160
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10229567
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/229567 | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens | Aug 26, 2002 | Issued |
Array
(
[id] => 6673823
[patent_doc_number] => 20030059426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Method for inducing selectively suppressed immune response to transplanted tissue or cells'
[patent_app_type] => new
[patent_app_number] => 10/217856
[patent_app_country] => US
[patent_app_date] => 2002-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8216
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10217856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/217856 | Method for inducing selectively suppressed immune response to transplanted tissue or cells | Aug 12, 2002 | Issued |
Array
(
[id] => 5720326
[patent_doc_number] => 20060073100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions'
[patent_app_type] => utility
[patent_app_number] => 10/216026
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 25801
[patent_no_of_claims] => 148
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10216026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/216026 | Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions | Aug 8, 2002 | Abandoned |
Array
(
[id] => 706811
[patent_doc_number] => 07060274
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Receptor specific transepithelial transport of therapeutics'
[patent_app_type] => utility
[patent_app_number] => 10/215297
[patent_app_country] => US
[patent_app_date] => 2002-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15032
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060274.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215297 | Receptor specific transepithelial transport of therapeutics | Aug 7, 2002 | Issued |
Array
(
[id] => 697920
[patent_doc_number] => 07067129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Receptor specific transepithelial transport in therapeutics'
[patent_app_type] => utility
[patent_app_number] => 10/215298
[patent_app_country] => US
[patent_app_date] => 2002-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15037
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067129.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215298 | Receptor specific transepithelial transport in therapeutics | Aug 7, 2002 | Issued |
Array
(
[id] => 551814
[patent_doc_number] => 07160683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'Method of testing for bronchial asthma'
[patent_app_type] => utility
[patent_app_number] => 10/214793
[patent_app_country] => US
[patent_app_date] => 2002-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7723
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10214793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/214793 | Method of testing for bronchial asthma | Aug 6, 2002 | Issued |
| 10/070304 | L-selectin contrast agents | Aug 6, 2002 | Abandoned |
Array
(
[id] => 6715416
[patent_doc_number] => 20030026764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Polymeric delivery systems'
[patent_app_type] => new
[patent_app_number] => 10/209592
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18658
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20030026764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209592 | Polymeric delivery systems | Jul 30, 2002 | Abandoned |
Array
(
[id] => 6778631
[patent_doc_number] => 20030049712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Method of detecting protease activity in a cell'
[patent_app_type] => new
[patent_app_number] => 10/209316
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10930
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049712.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209316
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209316 | Method of detecting protease activity in a cell | Jul 29, 2002 | Abandoned |
Array
(
[id] => 6692594
[patent_doc_number] => 20030040026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Isolation of membrane bound ligand-specific complexes'
[patent_app_type] => new
[patent_app_number] => 10/209328
[patent_app_country] => US
[patent_app_date] => 2002-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8543
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040026.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209328
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209328 | Isolation of membrane bound ligand-specific complexes | Jul 28, 2002 | Abandoned |
Array
(
[id] => 978812
[patent_doc_number] => 06929923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-16
[patent_title] => 'Modulators of leukocyte activation, BIC compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/202480
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 26
[patent_no_of_words] => 33143
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/929/06929923.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202480
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202480 | Modulators of leukocyte activation, BIC compositions and methods of use | Jul 22, 2002 | Issued |
Array
(
[id] => 6692593
[patent_doc_number] => 20030040025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Method for evaluating immunotoxicity of test substance'
[patent_app_type] => new
[patent_app_number] => 10/200164
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11350
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200164
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200164 | Method for evaluating immunotoxicity of test substance | Jul 22, 2002 | Issued |
Array
(
[id] => 7398032
[patent_doc_number] => 20040018567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/202481
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 35664
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202481
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202481 | Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use | Jul 22, 2002 | Issued |
Array
(
[id] => 1037419
[patent_doc_number] => 06872567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-29
[patent_title] => 'Method for separating cells using immunorosettes'
[patent_app_type] => utility
[patent_app_number] => 10/193092
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10328
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193092 | Method for separating cells using immunorosettes | Jul 11, 2002 | Issued |